These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 29778554)

  • 41. Ovarian response to controlled ovarian stimulation in women with different polycystic ovary syndrome phenotypes.
    Cela V; Obino MER; Alberga Y; Pinelli S; Sergiampietri C; Casarosa E; Simi G; Papini F; Artini PG
    Gynecol Endocrinol; 2018 Jun; 34(6):518-523. PubMed ID: 29271274
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association between progesterone to number of mature oocytes index and live birth in GnRH antagonist protocols.
    Simon C; Branet L; Moreau J; Gatimel N; Cohade C; Lesourd F; Parinaud J; Leandri R
    Reprod Biomed Online; 2019 Jun; 38(6):901-907. PubMed ID: 30952493
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Relationship between follicular volume and oocyte competence, blastocyst development and live-birth rate: optimal follicle size for oocyte retrieval.
    Wirleitner B; Okhowat J; Vištejnová L; Králíčková M; Karlíková M; Vanderzwalmen P; Ectors F; Hradecký L; Schuff M; Murtinger M
    Ultrasound Obstet Gynecol; 2018 Jan; 51(1):118-125. PubMed ID: 29134715
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A Slower Age-Related Decline in Treatment Outcomes After the First Ovarian Stimulation for
    Li J; Liu X; Hu L; Zhang F; Wang F; Kong H; Dai S; Guo Y
    Front Endocrinol (Lausanne); 2019; 10():834. PubMed ID: 31866942
    [No Abstract]   [Full Text] [Related]  

  • 45. In-vitro maturation versus IVF with GnRH antagonist for women with polycystic ovary syndrome: treatment outcome and rates of ovarian hyperstimulation syndrome.
    Das M; Son WY; Buckett W; Tulandi T; Holzer H
    Reprod Biomed Online; 2014 Nov; 29(5):545-51. PubMed ID: 25262236
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Effect of hyperandrogenism on pregnancy outcomes in women with polycystic ovary syndrome undergoing in vitro fertilization/intracytoplasmic sperm injection-embryo transfer].
    Jiang LL; Pan P; Jiao XD; Qiu Q; Li Y; Zhang QX
    Zhonghua Yi Xue Za Zhi; 2023 Apr; 103(14):1042-1048. PubMed ID: 37032154
    [No Abstract]   [Full Text] [Related]  

  • 47. Cumulative live birth rates in more than 3,000 patients with poor ovarian response: a 15-year survey of final in vitro fertilization outcome.
    Xu B; Chen Y; Geerts D; Yue J; Li Z; Zhu G; Jin L
    Fertil Steril; 2018 Jun; 109(6):1051-1059. PubMed ID: 29935642
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fresh
    Le TMC; Ong PT; Nguyen QA; Roque M
    JBRA Assist Reprod; 2022 Aug; 26(3):450-459. PubMed ID: 35191632
    [TBL] [Abstract][Full Text] [Related]  

  • 49. High ovarian response does not jeopardize ongoing pregnancy rates and increases cumulative pregnancy rates in a GnRH-antagonist protocol.
    Fatemi HM; Doody K; Griesinger G; Witjes H; Mannaerts B
    Hum Reprod; 2013 Feb; 28(2):442-52. PubMed ID: 23136144
    [TBL] [Abstract][Full Text] [Related]  

  • 50. High serum Antimullerian hormone levels are associated with lower live birth rates in women with polycystic ovarian syndrome undergoing assisted reproductive technology.
    Tal R; Seifer CM; Khanimov M; Seifer DB; Tal O
    Reprod Biol Endocrinol; 2020 Mar; 18(1):20. PubMed ID: 32156287
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Association between hyperandrogenism and adverse pregnancy outcomes in patients with different polycystic ovary syndrome phenotypes undergoing
    Ma L; Cao Y; Ma Y; Zhai J
    Gynecol Endocrinol; 2021 Aug; 37(8):694-701. PubMed ID: 33703999
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Success rates in minimal stimulation cycle IVF with clomiphene citrate only.
    Abe T; Yabuuchi A; Ezoe K; Skaletsky H; Fukuda J; Ueno S; Fan Y; Goldsmith S; Kobayashi T; Silber S; Kato K
    J Assist Reprod Genet; 2020 Feb; 37(2):297-304. PubMed ID: 31867688
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Outcomes After a Single Ovarian Stimulation Cycle in Women of Advanced Reproductive Age: A Retrospective Analysis.
    Liu M; Zhao X; Peng Y; Zheng J; Guo K; Fan Y; Jiang L; Yang A; Cui N; Hao G; Wang W
    Front Endocrinol (Lausanne); 2022; 13():792159. PubMed ID: 35237234
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Independent Variables for Determining the Cumulative Live Birth Rates of Aged Patients with Polycystic Ovary Syndrome or Tubal Factor Infertility: A Retrospective Cohort Study.
    Guan Y; Kong P; Xiao Z; Zhang J; He J; Geng W; Yan J; Sun S; Mu M; Du X; Wang X
    Front Endocrinol (Lausanne); 2021; 12():728051. PubMed ID: 35111134
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Predictive model of IVF outcomes for polycystic ovarian morphology and polycystic ovary syndrome in GnRH antagonist protocol using AMH-MoM and ovarian sensitivity index.
    Ko YR; Yu EJ; Park JE; Park JK; Eum JH; Kim TH; Lee WS; Lee HJ
    J Obstet Gynaecol Res; 2024 Sep; 50(9):1667-1674. PubMed ID: 38937259
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prevalence, clinical characteristics, and reproductive outcomes of polycystic ovary syndrome in older women referred for tertiary fertility care.
    Tannus S; Tan J; Son WY; Dahan MH
    Arch Gynecol Obstet; 2018 Apr; 297(4):1037-1042. PubMed ID: 29289990
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Follitropin alpha versus beta in a first GnRH antagonist ICSI cycle: a retrospective cohort study.
    Van den Haute L; Drakopoulos P; Verheyen G; De Vos M; Tournaye H; Blockeel C
    Reprod Biomed Online; 2021 Oct; 43(4):655-662. PubMed ID: 34474975
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Does oral contraceptives pretreatment affect the pregnancy outcome in polycystic ovary syndrome women undergoing ART with GnRH agonist protocol?
    Xu Z; Meng L; Pan C; Chen X; Huang X; Yang H
    Gynecol Endocrinol; 2019 Feb; 35(2):124-127. PubMed ID: 30303700
    [TBL] [Abstract][Full Text] [Related]  

  • 59. High anti-Mullerian hormone level is adversely associated with cumulative live birth rates of two embryo transfers after the first initiated cycle in patients with polycystic ovary syndrome.
    Su N; Zhan J; Xie M; Zhao Y; Huang C; Wang S; Liao L; Zhang X; Liu F
    Front Endocrinol (Lausanne); 2023; 14():1123125. PubMed ID: 37388214
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Required number of blastocysts transferred, and oocytes retrieved to optimize live and cumulative live birth rates in the first complete cycle of IVF for autologous and donated oocytes.
    Cubillos-García SP; Revilla-Pacheco F; Meneses-Mayo M; Rodríguez-Guerrero RE; Cuneo-Pareto S
    Arch Gynecol Obstet; 2024 Nov; 310(5):2681-2690. PubMed ID: 39231831
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.